Ceribell (CBLL)
Lets frontline nurses screen ICU patients for seizures with a six-minute bedside EEG headband.
Something off on this page? Send us feedback.
Makes a portable EEG headband and recorder that a nurse can apply to an ICU patient within six minutes, paired with an AI layer that flags seizures automatically and alerts the care team around the clock. Revenue comes from selling single-use headbands alongside a recurring software subscription for the detection and monitoring layer.
Makes a bedside headband-and-recorder system that screens ICU and emergency patients for seizures, built so a floor nurse rather than a specialist can apply it and get a reading within six minutes. An AI layer on top of the hardware flags abnormal activity and alerts the care team continuously, extending coverage beyond the hours a dedicated EEG reader is available.
Revenue splits between single-use headbands sold per patient and a recurring software subscription covering the detection algorithm, recorder, and clinician portal. Clearances have widened from adult seizure detection to pediatric and neonatal patients, and the same platform now covers delirium monitoring, with stroke detection under regulatory review.
Adoption runs hospital by hospital against an installed base of conventional EEG systems from established neurodiagnostics vendors, and further indication clearances remain central to expanding use beyond acute seizure care.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 3, 2026 | Raymond James | Reiterate | Rating: —Target: — | Target: $29 |
| Aug 18, 2026 | Barclays | Upgrade | Rating: — | |
| Aug 11, 2026 | Canaccord Genuity | Reiterate | Rating: —Target: $25 | Target: $26 |
| May 12, 2026 | Canaccord Genuity | Reiterate | Rating: —Target: $30 | Target: $25 |
| Dec 15, 2025 | BTIG | Reiterate | Rating: —Target: — | Target: $30 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $129.3M · Total debt $21.9M · Total assets $166.3M · Shareholders' equity $128.3M
- Revenue
- $28.1M
- Operating income
- −$20.0M
- Net income
- −$19.3M
No dividends on record.
| Institutions | ≈ 80.20% | 30.78M shares | |
|---|---|---|---|
| 126 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 9.75% | 3.74M shares | |
| 13 holders · as of Sep 17, 2026 | |||
| Strategic holders | 5.75% | 2.21M shares | |
| 1 holder · as of Feb 14, 2025 | |||
| Other | ≈ 4.30% | 1.65M shares | |
| remainder | |||
38.38M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
FMR LLCInstitution | 14.83% | 5.69M | as of Jun 30, 2026 |
TPG GP A, LLCInstitution | 9.80% | 3.76M | as of Jun 30, 2026 |
Red Tree Management, LLCInstitution | 5.75% | 2.21M | as of Jun 30, 2026 |
Red Tree GP, LLCStrategic | 5.75% | 2.21M | filed Feb 14, 2025 |
Josef Parvizi1Insiderdirector | 5.21% | 2.08M | filed Jun 4, 2026 |
- Josef Parvizi's transaction reports restate only vehicles that traded; the 2025 ownership statement (2.08M) less the 83.3K net shares sold since is used instead.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 15, 2026 | Xingjuan Chao | director, officer: President and CEO | −20,846 | $25.03 |
| Sep 15, 2026 | Scott Blumberg | officer: Chief Financial Officer | −846 | $25.00 |
| Sep 8, 2026 | Raymond Woo | officer: Chief Technology Officer | −4,887 | $24.33 |
| Sep 8, 2026 | David Foehr | officer: Senior VP, Finance and PAO | −9,255 | $24.25 |
| Sep 2, 2026 | Scott Blumberg | officer: Chief Financial Officer | −652 | $25.00 |
- GE HealthCare
Bundles EEG and BIS as add-on modules inside multi-parameter ICU monitors
- Philips (ADR)
Multi-parameter monitor EEG module for IntelliVue bedside platforms
- Compass Minerals
Clinical EEG amplifiers for LTM and ICU studies via Neuroscan Grael
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Ceribell | $24.50 | +1.04% | $920.1M | — | — | 9.0 | +32.5% |
| GE HealthCare | $67.06 | +3.47% | $29.27B | 18.8 | 12.9 | 1.4 | +5.8% |
| Philips (ADR) | $24.96 | +0.24% | $24.34B | 18.7 | 13.0 | 1.2 | −2.8% |
| Compass Minerals | $23.81 | +1.00% | $989.0M | 54.8 | 19.4 | 0.8 | +0.3% |
| Median | 18.8 | 13.0 | 1.2 | +0.3% |